Migdal Insurance & Financial Holdings’s Clovis Oncology, Inc. CLVS Stock Holding History

Migdal Insurance & Financial Holdings’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-416	Closed	-$3K	–	690
2021 Q1	$3K	Buy	416 +208	+100%	+$1.4K	﹤0.01%	658
2020 Q4	$1K	Hold	208	–	–	﹤0.01%	646
2020 Q3	$1K	Hold	208	–	–	﹤0.01%	655
2020 Q2	$1K	Hold	208	–	–	﹤0.01%	697
2020 Q1	$1K	Hold	208	–	–	﹤0.01%	673
2019 Q4	$2K	Hold	208	–	–	﹤0.01%	729
2019 Q3	$1K	Hold	208	–	–	﹤0.01%	734
2019 Q2	$3K	Hold	208	–	–	﹤0.01%	728
2019 Q1	$5K	Hold	208	–	–	﹤0.01%	688
2018 Q4	$4K	Buy	+208	New	+$4.25K	﹤0.01%	687

Other funds holding CLVS

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Migdal Insurance & Financial Holdings's CLVS Position: Q2 2021 in Review

Migdal Insurance & Financial Holdings sold out of Clovis Oncology, Inc. (CLVS) in Q2 2021, closing a stake of 416 shares — an estimated $3K sold.

Migdal Insurance & Financial Holdings first reported a position in CLVS in Q4 2018 and held it in 10 quarters. The position peaked at $5K in Q1 2019. 160 funds tracked by Wall St. Rank hold CLVS as of Q2 2021.

Migdal Insurance & Financial Holdings reported no remaining Clovis Oncology, Inc. position as of Q2 2021 after selling out during the quarter.
Migdal Insurance & Financial Holdings sold 416 Clovis Oncology, Inc. shares in Q2 2021, an estimated $3K.
Migdal Insurance & Financial Holdings first reported a position in Clovis Oncology, Inc. in Q4 2018 and held it in 10 quarters.
Migdal Insurance & Financial Holdings's Clovis Oncology, Inc. position peaked at $5K in Q1 2019.
160 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2021.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q2 2021, filed 4 Aug 2021.